Clinical Pharmacokinetics of Bambuterol
- 1 October 1996
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 31 (4) , 246-256
- https://doi.org/10.2165/00003088-199631040-00002
Abstract
Bambuterol, a biscarbamate ester prodrug of the β2adrenergic agonist terbutaline, has been approved for the treatment of asthma in 28 countries. It is available in 10 and 20mg (25 and 50 μmol)...Keywords
This publication has 43 references indexed in Scilit:
- Rapid Onset of Tolerance to the Bronchoprotective Effect of SalmeterolChest, 1995
- Interactions of bambuterol with human serum cholinesterase of the genotypes EuEu (normal), EaEa (atypical) and EuEaBiochemical Pharmacology, 1991
- The effect of bambuterol (carbamylated terbutaline) on plasma cholinesterase activity and suxamethonium-induced neuromuscular blockade in genotypically normal patientsActa Anaesthesiologica Scandinavica, 1990
- The influence of 10 mg and 20 mg of bambuterol on the duration of succinylcholine‐induced neuromuscular blockadeActa Anaesthesiologica Scandinavica, 1990
- The Influence of Bambuterol (Carbamylated Terbutaline) on the Duration of Action of Succinylcholine-induced Paralysis in HumansAnesthesiology, 1988
- BAMBUTEROL, A CARBAMATE ESTER PRODRUG OF TERBUTALINE, AS INHIBITOR OF CHOLINESTERASES IN HUMAN-BLOOD1988
- Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice dailyEuropean Respiratory Journal, 1988
- Bambuterol: Clinical Effects of Different Doses of a Long-Acting Bronchodilator ProdrugRespiration, 1988
- Asthma at night.1983
- Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men.BMJ, 1976